Cancer Drugs Not Cure

Article

SAN FRANCISCO, Calif-Drugs that were once touted as the cure to cancer have shown only a slight benefit in testing.

The dramatic tumor shrinkage or disappearance that doctors originally predicted from drugs has not happened in trial studies. The three drugs discovered within Judah Folkman's, MD, lab are within a new field pioneered by the physician and his team. Angiogensis, which starves tumors with chemicals and stops them form building new blood vessels, includes endostatin and angiostatin drugs. Both drugs were discovered by Michael O'Reilly, MD.

An article in The New York Times incorrectly labeled these new drugs as a possible cancer cure. However, only in a few cases have the drugs stopped growing cancer. In some cases the drug has halted cancer in some parts of the body, while having little effect elsewhere. The drugs do seem to slow the flow of blood to the patient's tumor.

The researchers will move on with these drugs and see if they are more effective when combined with chemotherapy and radiation.

Information from www.washingtonpost.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.